Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics-Reference-Cited by-同舟云学术

Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics

Published:2018-01-10 Issue:3 Volume:7 Page:233-243
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Ye Naidong¹,Monk Scott A.²,Daga Pankaj¹,Bender David M.²,Rosen Laura B.¹,Mullen Jamie¹,Minkwitz Margaret C.¹,Kugler Alan R.¹

Affiliation:

1. AstraZeneca; Cambridge MA USA

2. Lilly Research Laboratories; Eli Lilly and Company; Indianapolis IN USA

Funder

AstraZeneca

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference33 articles.

1. Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects;Vassar;J Neurochem.,2014

2. Advances in Alzheimer's disease drug development;Rafii;BMC Med.,2015

3. Dementia: a global health priority - highlights from an ADI and World Health Organization report;Wortmann;Alzheimers Res Ther.,2012

4. Prince M Guerchet M Prina M Alzheimer's Disease International: The Global Impact of Dementia 2013-2050 2013 https://www.alz.co.uk/research/GlobalImpactDementia2013.pdf

5. The Alzheimer's disease beta-secretase enzyme, BACE1;Cole;Mol Neurodegener,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Alzheimer's Treatment Landscape: UnravelingAmyloid-beta Complexities and Pioneering Precision MedicineApproaches;Current Topics in Medicinal Chemistry;2024-07

2. Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease;Ageing Research Reviews;2024-06

3. Alzheimer’s Disease: Treatment of Multi-Factorial Disorders with Multi- Target Approach;Mini-Reviews in Medicinal Chemistry;2023-03

4. BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?;Molecules;2022-12-12

5. Insights for Alzheimer's disease pharmacotherapy and current clinical trials;Neurochemistry International;2022-10